Alibaba to pay US $600M to settle allegations it allowed illegal drug and equipment sales

Alibaba will pay $600 million to the U.S. government to settle allegations that its platforms allowed the sale and import of illegal pharmaceuticals, controlled substances, and related equipment between 2016 and 2024. The settlement resolves claims that Alibaba’s U.S. payment processor failed to prevent unlawful transactions, leading to a non-prosecution agreement with the Justice Department.